US 11326156
Modified caspase-9 polypeptides and methods of use thereof
granted A61KA61K2239/23A61K31/7088
Quick answer
US patent 11326156 (Modified caspase-9 polypeptides and methods of use thereof) held by Allogene Therapeutics, Inc. expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Allogene Therapeutics, Inc.
- Grant date
- Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2239/23, A61K31/7088, A61K35/17, A61K38/4873